Quarterly report pursuant to sections 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.6
Consolidated Statements of Operations (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Revenue $ 6,311,401 $ 1,148,247
Cost of sales 3,650,188 1,187,713
Gross profit (loss) 2,661,213 (39,466)
Selling, general and administrative:    
Severance and transition costs 805,299  
Acquisition related expense 1,054,607  
Amortization and stock based compensation 1,142,169 89,863
Other selling, general and administrative 2,091,481 1,397,857
Research and development 459,438 197,172
Total operating expenses 5,552,994 1,684,892
Operating loss (2,891,781) (1,724,358)
Non-operating income (expense):    
Change in fair value of embedded derivative (3,169,083)  
Gain on bargain purchase of business 742,750  
Other income (expense) 31 (46,828)
Total non-operating expense, net (2,426,302) (46,828)
Loss from continuing operations (5,318,083) (1,771,186)
Provision for income taxes      
Discontinued operations:    
Income from discontinued operations   683
Net loss (5,318,083) (1,770,503)
Accrual of preferred stock dividends (277,083)  
Accretion to redemption value of Series E preferred stock (2,170,650)  
Net loss attributable to common stockholders $ (7,765,816) $ (1,770,503)
Basic and diluted loss per common share:    
Loss from continuing operations attributable to common stockholders $ (0.11) $ (0.11)
Discontinued operations $ 0.00 $ 0.00
Net loss attributable to common stockholders $ (0.11) $ (0.11)
Basic and diluted weighted average shares outstanding 71,658,506 16,452,738